| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability A Umar, CR Boland, JP Terdiman, S Syngal, A Chapelle, J Rüschoff, ... Journal of the National Cancer Institute 96 (4), 261-268, 2004 | 3795 | 2004 |
| Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors NM Lindor, LJ Burgart, O Leontovich, RM Goldberg, JM Cunningham, ... Journal of clinical oncology 20 (4), 1043-1048, 2002 | 969 | 2002 |
| Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review NM Lindor, GM Petersen, DW Hadley, AY Kinney, S Miesfeldt, KH Lu, ... Jama 296 (12), 1507-1517, 2006 | 786 | 2006 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 757 | 2012 |
| Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome S Kitao, A Shimamoto, M Goto, RW Miller, WA Smithson, NM Lindor, ... Nature genetics 22 (1), 82-84, 1999 | 755 | 1999 |
| Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ... JAMA oncology 1 (1), 23-32, 2015 | 714 | 2015 |
| Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X NM Lindor, K Rabe, GM Petersen, R Haile, G Casey, J Baron, S Gallinger, ... Jama 293 (16), 1979-1985, 2005 | 680 | 2005 |
| Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for … AR Sepulveda, SR Hamilton, CJ Allegra, W Grody, AM Cushman-Vokoun, ... American journal of clinical pathology 147 (3), 221-260, 2017 | 650 | 2017 |
| The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter, ... Gastroenterology 135 (2), 419-428. e1, 2008 | 640 | 2008 |
| Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes SN Thibodeau, AJ French, PC Roche, JM Cunningham, DJ Tester, ... Cancer research 56 (21), 4836-4840, 1996 | 602 | 1996 |
| Identification of Lynch syndrome among patients with colorectal cancer L Moreira, F Balaguer, N Lindor, A De la Chapelle, H Hampel, ... Jama 308 (15), 1555-1565, 2012 | 601 | 2012 |
| Increased risk for cancer in patients with the Peutz-Jeghers syndrome LA Boardman, SN Thibodeau, DJ Schaid, NM Lindor, SK McDonnell, ... Annals of internal medicine 128 (11), 896-899, 1998 | 590 | 1998 |
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility ME Robson, AR Bradbury, B Arun, SM Domchek, JM Ford, HL Hampel, ... Journal of Clinical Oncology 33 (31), 3660-3667, 2015 | 588 | 2015 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 547 | 2015 |
| Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder CA Wise, JD Gillum, CE Seidman, NM Lindor, R Veile, S Bashiardes, ... Human molecular genetics 11 (8), 961-969, 2002 | 538 | 2002 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database M Dominguez-Valentin, JR Sampson, TT Seppälä, SW Ten Broeke, ... Genetics in Medicine 22 (1), 15-25, 2020 | 493 | 2020 |
| The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience GS Oderich, JM Panneton, TC Bower, NM Lindor, KJ Cherry Jr, AA Noel, ... Journal of Vascular Surgery 42 (1), 98-106, 2005 | 456 | 2005 |
| Microduplication 22q11. 2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients RE Ensenauer, A Adeyinka, HC Flynn, VV Michels, NM Lindor, ... The American Journal of Human Genetics 73 (5), 1027-1040, 2003 | 455 | 2003 |
| Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers L Baglietto, NM Lindor, JG Dowty, DM White, A Wagner, ... Journal of the national cancer institute 102 (3), 193-201, 2010 | 451 | 2010 |
| Prediction of germline mutations and cancer risk in the Lynch syndrome S Chen, W Wang, S Lee, K Nafa, J Lee, K Romans, P Watson, SB Gruber, ... Jama 296 (12), 1479-1487, 2006 | 446 | 2006 |
